Literature DB >> 25081748

Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.

Christopher P Larsen1, Marjorie L Beggs1, Mohammad Saeed1, Josephine M Ambruzs1, L Nicholas Cossey1, Nidia C Messias1, Patrick D Walker1, Barry I Freedman2.   

Abstract

The effects of nephropathy risk variants in the apolipoprotein L1 gene (APOL1) on renal histopathology in African Americans with arterionephrosclerosis or putative 'hypertension-associated' nephropathy are unknown. APOL1 genotype-phenotype correlations were performed in a blinded manner from renal biopsies in 196 self-reported African Americans with arterionephrosclerosis on kidney biopsy at a large national nephropathology practice. Subjects had chronic kidney disease without nephrotic syndrome. A discovery analysis compared histopathologic changes in the glomerular and tubulointerstitial compartments in 58 subjects with 2 versus 56 subjects with 0 APOL1 risk variants. Validation was performed in biopsies from 82 additional subjects with 0, 1, and 2 risk variants. Two risk variant versus zero risk variant group genotype associations and subphenotypes were assessed by χ(2) analyses. ANOVA compared means of continuous variables. In discovery analyses, significantly less obsolescent glomerulosclerosis, more (solidified and disappearing) glomerulosclerosis, more thyroidization-type tubular atrophy, and more microcystic tubular dilatation were seen in patients with two versus zero APOL1 risk alleles. Greater degrees of arteriosclerosis were present in those with zero risk alleles. Segmental glomerulosclerosis did not differ significantly between groups. Presence of two of the following discriminatory histopathologic findings from discovery, that is, <50% obsolescent glomerulosclerosis, thyroidization-type tubular atrophy, and microcystic tubular dilatation, was specific for the presence of two APOL1 risk alleles in the validation phase. African Americans with arterionephrosclerosis who possess two APOL1 risk variants more often lack obsolescent glomerulosclerosis and have greater degrees of (solidified and disappearing) glomerulosclerosis, thyroidization-type tubular atrophy, and microcystic tubular dilation than patients with fewer than two risk variants. These findings support involvement of multiple cell types in subnephrotic forms of APOL1-associated nephropathy, particularly renal tubule cells with resultant tubulointerstitial disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25081748     DOI: 10.1038/modpathol.2014.92

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  26 in total

Review 1.  Genetics of kidney failure and the evolving story of APOL1.

Authors:  David J Friedman; Martin R Pollak
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

2.  Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.

Authors:  Lewis H Kuller; Gregory Grandits; Jerome D Cohen; James D Neaton; Ronald Prineas
Journal:  Atherosclerosis       Date:  2006-10-02       Impact factor: 5.162

3.  End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.

Authors:  Barry I Freedman; Carl D Langefeld; Kelly K Andringa; Jennifer A Croker; Adrienne H Williams; Neva E Garner; Daniel J Birmingham; Lee A Hebert; Pamela J Hicks; Mark S Segal; Jeffrey C Edberg; Elizabeth E Brown; Graciela S Alarcón; Karen H Costenbader; Mary E Comeau; Lindsey A Criswell; John B Harley; Judith A James; Diane L Kamen; S Sam Lim; Joan T Merrill; Kathy L Sivils; Timothy B Niewold; Neha M Patel; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Jane E Salmon; Betty P Tsao; Keisha L Gibson; Joyce R Byers; Anna K Vinnikova; Janice P Lea; Bruce A Julian; Robert P Kimberly
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

4.  Hypertension-misattributed kidney disease in African Americans.

Authors:  Karl L Skorecki; Walter G Wasser
Journal:  Kidney Int       Date:  2013-01       Impact factor: 10.612

5.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

Authors:  Allison E Ashley-Koch; Emmanuel C Okocha; Melanie E Garrett; Karen Soldano; Laura M De Castro; Jude C Jonassaint; Eugene P Orringer; James R Eckman; Marilyn J Telen
Journal:  Br J Haematol       Date:  2011-09-13       Impact factor: 6.998

6.  Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators.

Authors:  A Fogo; J A Breyer; M C Smith; W H Cleveland; L Agodoa; K A Kirk; R Glassock
Journal:  Kidney Int       Date:  1997-01       Impact factor: 10.612

7.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

8.  A contribution to the morphology and pathogenesis of thyroid-like lesions in the kidney.

Authors:  H G Laberke; T Klingebiel; G Quack
Journal:  Pathol Res Pract       Date:  1983-03       Impact factor: 3.250

9.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.

Authors:  Shay Tzur; Saharon Rosset; Revital Shemer; Guennady Yudkovsky; Sara Selig; Ayele Tarekegn; Endashaw Bekele; Neil Bradman; Walter G Wasser; Doron M Behar; Karl Skorecki
Journal:  Hum Genet       Date:  2010-07-16       Impact factor: 4.132

10.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.

Authors:  Michael S Lipkowitz; Barry I Freedman; Carl D Langefeld; Mary E Comeau; Donald W Bowden; W H Linda Kao; Brad C Astor; Erwin P Bottinger; Sudha K Iyengar; Paul E Klotman; Richard G Freedman; Weijia Zhang; Rulan S Parekh; Michael J Choi; George W Nelson; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Kidney Int       Date:  2012-07-25       Impact factor: 10.612

View more
  30 in total

Review 1.  One Actor, Many Roles: Histopathologies Associated With APOL1 Genetic Variants.

Authors:  Jeffrey B Kopp; Avi Z Rosenberg
Journal:  Adv Anat Pathol       Date:  2019-05       Impact factor: 3.875

2.  Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.

Authors:  Pazit Beckerman; Jing Bi-Karchin; Ae Seo Deok Park; Chengxiang Qiu; Patrick D Dummer; Irfana Soomro; Carine M Boustany-Kari; Steven S Pullen; Jeffrey H Miner; Chien-An A Hu; Tibor Rohacs; Kazunori Inoue; Shuta Ishibe; Moin A Saleem; Matthew B Palmer; Ana Maria Cuervo; Jeffrey B Kopp; Katalin Susztak
Journal:  Nat Med       Date:  2017-02-20       Impact factor: 53.440

3.  Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.

Authors:  Christopher P Larsen; Barry I Freedman
Journal:  J Am Soc Nephrol       Date:  2015-01-08       Impact factor: 10.121

Review 4.  Therapeutics for APOL1 nephropathies: putting out the fire in the podocyte.

Authors:  Jurgen Heymann; Cheryl A Winkler; Maarten Hoek; Katalin Susztak; Jeffrey B Kopp
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

5.  APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study.

Authors:  Wendy E Hoy; Michael D Hughson; Jeffrey B Kopp; Susan A Mott; John F Bertram; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2015-06-02       Impact factor: 10.121

Review 6.  The conundrums of chronic kidney disease and aging.

Authors:  Richard J Glassock; Aleksandar Denic; Andrew D Rule
Journal:  J Nephrol       Date:  2016-11-25       Impact factor: 3.902

7.  Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa.

Authors:  Charlotte Osafo; Yemi Raheem Raji; David Burke; Bamidele O Tayo; Nicki Tiffin; Marva M Moxey-Mims; Rebekah S Rasooly; Paul L Kimmel; Akinlolu Ojo; Dwomoa Adu; Rulan S Parekh
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 8.237

8.  Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.

Authors:  Matthew G Sampson; Catherine C Robertson; Sebastian Martini; Laura H Mariani; Kevin V Lemley; Christopher E Gillies; Edgar A Otto; Jeffrey B Kopp; Anne Randolph; Virginia Vega-Warner; Felix Eichinger; Viji Nair; Debbie S Gipson; Daniel C Cattran; Duncan B Johnstone; John F O'Toole; Serena M Bagnasco; Peter X Song; Laura Barisoni; Jonathan P Troost; Matthias Kretzler; John R Sedor
Journal:  J Am Soc Nephrol       Date:  2015-07-06       Impact factor: 10.121

Review 9.  APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.

Authors:  Barry I Freedman; Sophie Limou; Lijun Ma; Jeffrey B Kopp
Journal:  Am J Kidney Dis       Date:  2018-11       Impact factor: 8.860

10.  Deep Learning Global Glomerulosclerosis in Transplant Kidney Frozen Sections.

Authors:  Jon N Marsh; Matthew K Matlock; Satoru Kudose; Ta-Chiang Liu; Thaddeus S Stappenbeck; Joseph P Gaut; S Joshua Swamidass
Journal:  IEEE Trans Med Imaging       Date:  2018-06-27       Impact factor: 10.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.